Key Market Indicators
Sales of beta-blocking medicines in Germany will drop slightly to $793 million by 2026, down 0.2% annually on average. This follows a steady rise since 1991, when sales amounted to $815 million in 2021. Italy, Canada and Australia are the second, third and fourth-largest markets for beta-blocking drugs, respectively.